Related references
Note: Only part of the references are listed.Magnetic resonance imaging signal reduction may precede volume loss in the pituitary gland of transfusion-dependent beta-thalassemic patients
Ali Hekmatnia et al.
ACTA RADIOLOGICA (2010)
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone
Maria Eliana Lai et al.
BLOOD CELLS MOLECULES AND DISEASES (2010)
Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major
Kallistheni Farmaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit
Vassilios Ladis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
The influence of treatment in specialized centers on survival of patients with thalassemia major
Gian Luca Forni et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Organ-specific hemosiderosis and functional correlation in Chinese patients with thalassemia intermedia and hemoglobin H disease
W. Y. Au et al.
ANNALS OF HEMATOLOGY (2009)
Pancreatic iron loading predicts cardiac iron loading in thalassemia major
Leila J. Noetzli et al.
BLOOD (2009)
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
Aurelio Maggio et al.
BLOOD CELLS MOLECULES AND DISEASES (2009)
Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit
Giorgos Chouliaras et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study
Vasilios Berdoukas et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2009)
Safety and efficacy of pegylated interferon α-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia
Paul Harmatz et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance
Bernadette Modell et al.
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE (2008)
The pancreas in β-thalassemia major:: MR imaging features and correlation with iron stores and glucose disturbunces
Olympia Papakonstantinou et al.
EUROPEAN RADIOLOGY (2007)
A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance
M. A. Tanner et al.
CIRCULATION (2007)
Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major
C Borgna-Pignatti et al.
BLOOD (2006)
Reversal of heart failure in thalassemia major by combined chelation therapy: a case report
M Tsironi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major
KH Wu et al.
ANNALS OF HEMATOLOGY (2004)
Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance
LJ Anderson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload
LJ Anderson et al.
EUROPEAN HEART JOURNAL (2001)
Survival in β-thalassaemia major in the UK:: data from the UK thalassaemia register
B Modell et al.
LANCET (2000)
Share Paper
